Atlas Trials

Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer Pain

Clinical trial NCT04296305 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04296305
Sponsor
M.D. Anderson Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Start date
2020-09-10
Primary completion
2027-12-31
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.